Join a live webinar workshop focused on Psychedelics, Neuroinflammation, and Neurologic Disease
Important Webinar Details
- Format: Live online webinar
- Duration: 2 hours (~60 minutes lecture and ~60 minutes case discussion and audience Q&A)
- Registration is $25 and includes access to the live workshop, a video recording, and downloadable PDF slides
- The recording will be available within 72 hours following the live event
- No refunds will be issued if you are unable to attend
Workshop Overview:
As interest in psychedelic therapies continues to expand, questions surrounding their safety and potential therapeutic role in neurologic conditions have become increasingly common. Disorders such as migraine and Parkinson’s disease involve complex neurochemical, inflammatory, and pharmacologic factors that require careful consideration when evaluating psychedelic use.
This 2-hour webinar, led by Dr. Benjamin Malcolm, PharmD, MPH, provides an evidence-informed exploration of the intersection between psychedelics, neuroinflammation, headache disorders, and neurodegenerative disease.
The first half of the workshop will present a structured lecture reviewing preclinical and clinical data on the immunomodulatory and neurologic effects of psychedelics, including proposed mechanisms relevant to migraine or cluster headaches and Parkinson’s disease
The second half of the session will focus on two case discussions and accompanying multiple choice questions, applying the lecture content to two real-world clinical scenarios:
- A patient with episodic migraine considering psilocybin, LSD, or DMT while using standard abortive and preventive therapies
- A patient with early-stage Parkinson’s disease and depression exploring potential risks and benefits of psychedelic-assisted therapy in the context of dopaminergic and MAO-B–inhibiting medications
Participants will work through medication interactions, disease-specific risks, candidate selection, and harm-reduction strategies, followed by a facilitated group discussion and live Q&A.
By integrating clinical pharmacology, current research, and practical decision-making frameworks, this webinar aims to help clinicians, facilitators, and psychedelic care professionals navigate neurologic complexity with greater confidence and caution.
Learning Objectives
- Outline preclinical and clinical evidence supporting potential anti-inflammatory and immunomodulatory effects of psychedelics
- Describe proposed mechanisms by which psychedelics may influence migraine and cluster headache disorders
- Discuss safety considerations, contraindications, and drug–drug interactions relevant to serotonergic psychedelics in neurologic conditions
- Evaluate risks and potential benefits of psychedelic use in Parkinson’s disease across stages of illness
- Apply lecture concepts to real-world migraine and Parkinson’s disease case scenarios
- Develop practical harm-reduction and screening strategies for individuals with neurologic comorbidities
Registration will trigger emails that have the workshop information containing the attendance link. Save this page or link so you can easily revisit.
The attendance link will also be available on the webpage immediately following registration.
It is your responsibility to follow up at admin@spiritpharmacist.com if you do not receive these emails at least 24 hours prior to the event.
In the case of gross technical difficulties (e.g. power outage, repeated or prolonged internet disruption) or other circumstances (e.g., illness, medical emergency) significantly effecting the workshop quality or precluding its occurrence, the workshop will be rescheduled to a different time.
Host Information
Dr. Ben Malcolm, PharmD, MPH - Founder of Spirit Pharmacist
Psychopharmacology Consultant and Psychedelic Educator
Dr. Ben Malcolm earned his bachelor’s degree (BS) in pharmacology at the University of California at Santa Barbara, prior to his Masters in Public Health (MPH) and Doctorate of Pharmacy (PharmD) at Touro University California. He then completed post-graduate residencies in Acute Care at Scripps Mercy Hospital and Psychiatric Pharmacy at the University of California at San Diego Health.
After residency he passed his exam to become Board Certified in Psychiatric Pharmacy (BCPP). He began his career as an Assistant Clinical Professor at Western University of Health Sciences (WUHS), College of Pharmacy before transitioning to his current entrepreneurial role as a Psychopharmacology Consultant, Psychedelic Educator, and Founder of https://www.spiritpharmacist.com
Ben envisions a society in which access to psychedelic drugs in a variety of safe and supported settings is available for purposes of psychospiritual well-being, personal development, ceremonial sacraments, and treatment of mental illness. His focus is on the intersection between psychiatric medications and psychedelic therapies. He has given several Continuing Education presentations to pharmacists and other healthcare professionals as well as published over a dozen articles in peer-reviewed literature relating to psychedelics or psychiatric medications.
His vision guides his clinical and education service-related professional activity.
Webinar Disclaimer
This webinar is for information and educational purposes only. It is not meant to condone or encourage the use of illicit substances. The information presented is not medical advice and should not be taken as such. It is recommended you follow laws applicable to your jurisdiction.